✉news TechnologyAI first seen 1 d ago, last 6 h ago, peak #16
AI companies turn to virtual drug trials
Original: AI companies run virtual drug trials, aim to improve success of human studies
AI companies are running simulated, or 'virtual', drug trials before moving treatments into human studies, Reuters reports. The approach uses AI models to predict how drugs will perform, with the goal of raising the historically low success rate of clinical trials in humans. If validated, virtual trials could cut the cost and time of drug development, though regulators and researchers will scrutinise how reliable such simulations really are.
Why now: AI's expanding role in pharmaceutical research is drawing attention as firms seek ways to improve clinical trial success rates.
Rank over time, top of the chart is #1. 12 snapshots from 1 d ago to 6 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1350271